Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: J Neurochem. 2015 May 4;134(2):354–370. doi: 10.1111/jnc.13127

Figure 7.

Figure 7

Hypothetical schematic model: CDK5 RNAi-induced protection and cognitive improvement in a pathological context that depended on the p35/Rac1 GTPase pathway. CDK5 shRNAmiR blocks calpain activation and the cleavage of p35 to p25 produced by glutamate, which generates neuroprotection in a p35 up-regulation dependent-mode and its down-stream control of Rho GTPases, such as Rac1 and RhoA.